BioPharma Reporter

SEPTEMBER 19, 2023

The big pharma company Bristol Myers Squibb (BMS) has recruited contract manufacturing and development organization (CDMO) Samsung Biologics to manufacture a commercial antibody cancer treatment until 2030.

Manufacturing 59

Manufacturing Contract Manufacturing Pharma Companies Antibody 59

Fossil Remedies

JULY 18, 2019

ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. The third-party pharma manufacturing model makes the whole process cost-effective. Cost-effective production.

Manufacturing 60

Manufacturing Pharma Companies Production Pharma Production 60

Pharmaceutical Technology

MAY 26, 2023

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

Outsourcing Pharma

JANUARY 26, 2023

Hataali has introduced a new version of its blockchain-based advanced therapy platform to address one of the key supply chain challenges faced by contract manufacturers and pharma companies today.

Contract Manufacturing 52

Contract Manufacturing Pharma Companies Manufacturing Drug Delivery 52

Fossil Remedies

APRIL 7, 2020

Irene Pharma – Being one of the prominent PCD Pharma company in India located at Ahmedabad Gujarat, we have faith in embracing new advances for consistently enhancing our PCD Pharma business operations. Wellona Pharma. Specialize in contract manufacturing and 3rd Party manufacturing pharma products.

Pharma Production 81

Pharma Production Pharma Companies Production Contract Manufacturing 81

Pharmaceutical Technology

JUNE 14, 2023

The increase in demand for CPO services today and over the last decade is evidence of the added value that they offer to pharma companies both large and small, especially as drug developers seek to claim their share of the evolving ATMP market while overcoming complex challenges in its supply chain.

Contract Packaging 130

Contract Packaging Packaging Packaging Development 130

Outsourcing Pharma

JANUARY 7, 2021

A leader from the chemical manufacturing firm notes pharma companies are showing increased interest in contracting out their manufacturing functions.

Reagent 69

Reagent Pharma Companies Manufacturing Contract Manufacturing 69

Pharmaceutical Technology

JUNE 14, 2023

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Of those, only 935 (34%) small molecule API facilities offered some type of containment capabilities.

Containment 130

Containment Manufacturing Contract Manufacturing Bioavailability 130

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Manufacturing these highly potent and often cytotoxic drugs introduces many risks for operators and the environment. But containment is not only important at commercial-stage manufacturing.

Containment 130

Containment Development Drugs Contract Manufacturing 130

pharmaphorum

JANUARY 3, 2023

It’s first marketing application was turned down in October 2021 with an FDA request for more technical and manufacturing information focusing on the xenon hyperpolariser system. The post FDA clears Polarean’s lung disease diagnostic Xenoview appeared first on.

Contract Manufacturing 64

Contract Manufacturing Manufacturing FDA Approval Pharma Companies 64

pharmaphorum

NOVEMBER 12, 2020

The mid-sized pharma group has also signed a collaboration with Florida, US-based Lacerta Therapeutics , adding more AAV capsids – well established as a staple for delivering gene therapy sequences – as well as another gene therapy candidate.

Gene Therapy 52

Gene Therapy Gene Manufacturing Contract Manufacturing 52

Outsourcing Pharma

MARCH 20, 2023

Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area.

Pharma Companies 52

Pharma Companies Drugs Contract Manufacturing Manufacturing 52

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

pharmaphorum

JULY 15, 2022

In the final piece of a three-part series, Ben Hargreaves explores how manufacturing infrastructure was rapidly built up to the required capacity to ensure sufficient supply of COVID-19 vaccines, and what still remains to be done to improve vaccine equity globally. No unqualified success.

Vaccination 115

Vaccination Vaccine Manufacturing Production 115

Pharmaceutical Technology

JULY 14, 2022

Regulatory decisions have a ripple effect, first affecting the pharma sponsors, and then the companies tasked to manufacture the drug. Pharmaceutical Technology looks at drugs and biologics with recent regulatory verdicts that will likely impact manufacturing volumes. Consequential FDA and EMA decisions.

Manufacturing 130

Manufacturing Drugs Vaccination Vaccine 130

Pharmaceutical Technology

JULY 4, 2022

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccination 195